首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
primary hyperuricemia相关文献:
Role of diet in hyperuricemia and gout.
Danve A, Sehra ST, Neogi T.
Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101723. doi: 10.1016/j.berh.2021.101723. Epub 2021 Nov 19.
PMID:34802900
The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
Eckenstaler R, Benndorf RA.
Int J Mol Sci. 2021 Jun 22;22(13):6678. doi: 10.3390/ijms22136678.
PMID:34206432
The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics.
Wu X, You C.
PeerJ. 2023 Jan 6;11:e14554. doi: 10.7717/peerj.14554. eCollection 2023.
PMID:36632144
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors.
Dehlin M, Jacobsson L, Roddy E.
Nat Rev Rheumatol. 2020 Jul;16(7):380-390. doi: 10.1038/s41584-020-0441-1. Epub 2020 Jun 15.
PMID:32541923
Circulating microRNA alternations in primary hyperuricemia and gout.
Bohatá J, Horváthová V, Pavlíková M, Stibůrková B.
Arthritis Res Ther. 2021 Jul 10;23(1):186. doi: 10.1186/s13075-021-02569-w.
PMID:34246297
Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements.
Li Q, Li X, Wang J, Liu H, Kwong JS, Chen H, Li L, Chung SC, Shah A, Chen Y, An Z, Sun X, Hemingway H, Tian H, Li S.
BMJ Open. 2019 Aug 24;9(8):e026677. doi: 10.1136/bmjopen-2018-026677.
PMID:31446403
Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N.
N Engl J Med. 2005 Dec 8;353(23):2450-61. doi: 10.1056/NEJMoa050373.
PMID:16339094
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review.
Terkeltaub R.
Drugs. 2023 Nov;83(16):1501-1521. doi: 10.1007/s40265-023-01944-y. Epub 2023 Oct 11.
PMID:37819612
How should we manage asymptomatic hyperuricemia?
Chalès G.
Joint Bone Spine. 2019 Jul;86(4):437-443. doi: 10.1016/j.jbspin.2018.10.004. Epub 2018 Oct 11.
PMID:30316974
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y; FEATHER Study Investigators.
Am J Kidney Dis. 2018 Dec;72(6):798-810. doi: 10.1053/j.ajkd.2018.06.028. Epub 2018 Sep 1.
PMID:30177485
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3